Winder Laboratories, LLC recalled 3,528 bottles of Morphine Sulfate Oral Solution on November 26, 2025. The labeling error misrepresented the product size, leading to potential dosing issues. Consumers should stop using the product immediately and consult their healthcare provider.
Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.
Consumers and healthcare providers should stop using this product immediately. Contact Winder Laboratories, LLC or your healthcare provider for guidance. Notification method: N/A
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The recalled product is Morphine Sulfate Oral Solution 100 mg / 5 mL, packaged in 30 mL bottles. It is classified as a prescription-only medication and carries the NDC code 75826-131-01. The product was distributed nationwide across the U.S.
The recall stems from a mispackaging issue where the size stated on the carton label did not match the actual size of the bottle. This discrepancy poses a high risk of incorrect dosing, which can lead to serious health complications.
There have been no reported injuries or incidents directly associated with this recall. However, the potential for dosing errors raises significant safety concerns.
Consumers and healthcare providers should stop using the recalled Morphine Sulfate Oral Solution immediately. Contact Winder Laboratories, LLC or your healthcare provider for further guidance on the recall and potential alternatives.
For further inquiries, consumers can reach Winder Laboratories, LLC directly. Visit the FDA recall page for more information at https://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?recall_number=D-0223-2026.
Get instant alerts for recalls that affect you. Free forever.
Glenmark Pharmaceuticals recalled nearly 97,000 packs of Ondansetron Orally Disintegrating Tablets on December 30, 2025. Defective blister packs may not fully seal, leading to tablets falling out. Consumers should stop using the product immediately and contact healthcare providers.
Novo Nordisk recalled Wegovy (semaglutide) injections on December 19, 2025, after discovering hair in prefilled syringes. The contamination poses a serious hazard to consumers. The recall affects all units distributed nationwide.
Novo Nordisk recalled Wegovy (semaglutide) Injection on December 19, 2025, due to hair found in a prefilled syringe. The recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and contact their healthcare provider.
Zydus Pharmaceuticals recalled over 2,100 bottles of TraZODONE Hydrochloride Tablets on December 19, 2025. Some tablets have surface dents that may affect medication integrity. Consumers should stop using the product immediately and seek guidance from healthcare providers.
CareFusion 213, LLC recalled 106,400 units of ChloraPrep Triple Swabsticks on December 17, 2025. The recall occurred due to a lack of assurance of sterility. Consumers must stop using the product immediately and contact CareFusion for guidance.
Merck Sharp & Dohme LLC recalled 845 kits of Noxafil Powdermix on December 12, 2025. The recall follows the discovery of potential metal particulates in the product. Consumers should stop using the medication immediately and contact their healthcare provider for further guidance.
Merck Sharp & Dohme LLC recalled 3 single-dose kits of Emend (aprepitant) on December 12, 2025. The recall stems from the potential presence of metal particulates in the medication. Consumers should immediately stop using the product and contact their healthcare provider for guidance.
Beaver-Visitec International recalled five units of the OME6000U Laser and Endoscopy System on December 5, 2025. The recall stems from a manufacturing deviation where ferrites required for the USB cable were not installed. This omission poses a high electrical hazard risk to patients and healthcare providers.